NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets protein-based biosurgery and passive immunotherapy products, announced today that Robert Taub, President and Chief Executive Officer, is scheduled to give a company presentation at the Citigroup 2007 Global Healthcare Conference on Tuesday, May 22, 2007 at 1:30 p.m. ET (10:30 a.m. PT) at the Hilton New York in New York City.
